GALACTIC HF
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction
- Stadium
- klaar
- Middel
- omecamtiv mecarbil
- Populatie
- Hartfalen
- Fase
- III
- First Patient In
- 6 juli 2017
- Last Patient In
- 28 juni 2019
- Last Patient Last Visit
- 30 september 2020